Genapsys

About

Transform the human condition by building a scalable, affordable genomic sequencing ecosystem that will support research and diagnostics

Redwood City,California,United States
101 - 250
http://genapsys.com

Highlights

Details

Last Funding Type: Convertable Note
Industries: Bioinformatics,Biotechnology,Genetics,Health Diagnostics,Life Science
Founded date: Jan 1, 2010
Number Of Employee: 101 - 250
Operating Status: Active
Legal Name: Genapsys Inc.

Our mission is to transform research and diagnostics with an affordable, scalable genomic sequencing ecosystem.

We believe in providing innovative sequencing solutions and high-quality service to our customers and partners. We lead with integrity and resiliency. We promise our stakeholders transparency, inclusivity and collaboration.

It was founded in 2010 and headquartered in Redwood City, California.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

9

$319M

Genapsys has raised a total of $319M in funding over 2 rounds. Their latest funding was raised on May 27, 2021 from a Series D round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
May 27, 2021	Series D	$70M	3	Farallon Capital Management	—	Detail
Feb 6, 2020	Debt Financing	$75M	1	Oxford Finance LLC	—	Detail
Nov 21, 2019	Series C	$90M	1	Foresite Capital	—	Detail
Jan 15, 2018	Series C	$32.50M	1	—	—	Detail
Mar 30, 2017	Convertable Note	—	—	—	—	Detail

Investors

Number of Lead Investors

Number of Investors

5

10

Genapsys is funded by 10 investors. Farallon Capital Management and Oxford Finance LLC are the most recent investors.

Investor Name	Lead Investor	Funding Round
Farallon Capital Management	Yes	Series D
Oxford Finance LLC	Yes	Debt Financing
Foresite Capital	Yes	Series C
IPV Capital	Yes	Series B
PBM Capital Group	—	Series D
Soleus Capital	—	Series D
Casdin Capital	—	Series C
Decheng Capital	—	Series B
National Human Genome Research Institute	—	Grant
Plug and Play	—	Convertable Note